Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Community driven content discussing all aspects of software development from DevOps to design patterns. To do that, you need practice, and that’s what this collection of GH-300 GitHub Copilot practice ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

Community driven content discussing all aspects of software development from DevOps to design patterns. So get ready to test your skills. Good luck on these practice questions, and even better luck ...

Nathan Brown has predictions for what will happen this weekend. Alex Palou holds a healthy lead in the points standings, but Pato O'Ward is trying to cut into it. The IndyCar Series goes to wine ...